Episode 6: The OPTIC study: Patient views on optimising immunotherapy in cancer

Trial Talk

İçerik UCL Minds tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan UCL Minds veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.

3M ago 25:24

MP3•Bölüm sayfası

Optimisation immunotherapy clinical trials investigate ways of reducing the intensity of immunotherapy cancer treatment. This could be beneficial for patients’ quality of life. But these trials can be challenging to run, as patients may be concerned about the impact that reducing the intensity of treatment could have on the cancer.

This episode of the Trial Talk podcast focuses on the MRC Clinical Trials Unit at UCL’s OPTIC study, which explores how people with cancer feel about taking part in optimisation immunotherapy trials. Clinical Fellow Sophie Merrick discusses the main barriers that patients face and recommendations to address them.

Resources:
•OPTIC study page: www.mrcctu.ucl.ac.uk/studies/all-st…/refine/optic/
•OPTIC results paper: www.nature.com/articles/s41416-024-02756-x.pdf
•REFINE podcast episode: on.soundcloud.com/Fe3C76csHkgCg2or5

For questions or feedback on the series, message us at mrcctu.engage@ucl.ac.uk

For more information and to access the transcript: bit.ly/4c9SfAr

As a listener, your opinion is very valuable to us. Please help us to improve the podcast in future by filling in this short survey: forms.office.com/e/PjfjQ5Mn6g

Date of episode recording: 2024-06-18T00:00:00Z
Duration: 00:25:23
Language of episode: English
Presenter: Berta Terre-Torras
Guests: Sophie Merrick
Producer: Berta Terre-Torras

25 bölüm

#Fitness #Podcasting Education #UCL Minds